To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
CP 55,940, is a cannabinoid which mimics the effects of naturally occurring THC (the psychoactive compound found in marijuana). CP 55,940 was created by Pfizer in 1974 and was never marketed because of its highly psychoactive nature. It is currently used by scientists to study cannabinoid effects in biology. Some effects that have been noted are a greatly decreased rates of lever pressing in exposed mice, and a greater reaction to opiates in exposed mice. CP-55940 is 45 times more potent than Δ9-THC, and fully antagonized by rimonabant (SR141716A) (Life Sci 1996;58:1239-47; last update 010106). CP 55940 produces cannabis-like effects in humans at a dose of 0.25 - 1 milligram and could potentially be used as an alternative to medicinal marijuana which would be illegal (schedule one) under analogue laws rather than by specific mention.
Additional recommended knowledge
There is no information on the dangers or Neurotoxicity of CP 55,940
There is no history of recreational use of CP 55,940
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "CP_55,940". A list of authors is available in Wikipedia.|